Global Anti-Smoking Products Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Anti-Smoking Products Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
The smoking cessation and nicotine de-addiction market is categorized into three major segments including drug therapy, Nicotine Replacement Therapy (NRT), and Electronic cigarettes (E-cigarettes).
Anti-Smoking Products report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Anti-Smoking Products market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Smokers aged 18–24 and Smokers aged 25–44 are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Anti-Smoking Products industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Anti-Smoking Products key companies include Pfizer, Cipla, Novartis International, GSK, Takeda pharmaceutical, McNeil AB, Revolymer plc, Imperial Tobacco and Elder Pharma, etc. Pfizer, Cipla, Novartis International are top 3 players and held % share in total in 2022.
Anti-Smoking Products can be divided into Nicotine Replacement Therapy, Drug therapy and E-cigarettes,, etc. Nicotine Replacement Therapy is the mainstream product in the market, accounting for % share globally in 2022.
Anti-Smoking Products is widely used in various fields, such as Smokers aged 18–24, Smokers aged 25–44, Smokers aged 45–64 and Smokers aged 65 years or older, etc. Smokers aged 18–24 provides greatest supports to the Anti-Smoking Products industry development. In 2022, global % share of Anti-Smoking Products went into Smokers aged 18–24 filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anti-Smoking Products market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Pfizer
Cipla
Novartis International
GSK
Takeda pharmaceutical
McNeil AB
Revolymer plc
Imperial Tobacco
Elder Pharma
NJOY
VMR products
Lorillard
VaporCorp
Segment by Type
Nicotine Replacement Therapy
Drug therapy
E-cigarettes
Smokers aged 18–24
Smokers aged 25–44
Smokers aged 45–64
Smokers aged 65 years or older
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Anti-Smoking Products market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Anti-Smoking Products introduction, etc. Anti-Smoking Products Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Anti-Smoking Products market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Anti-Smoking Products report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Anti-Smoking Products market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Smokers aged 18–24 and Smokers aged 25–44 are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Anti-Smoking Products industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Anti-Smoking Products key companies include Pfizer, Cipla, Novartis International, GSK, Takeda pharmaceutical, McNeil AB, Revolymer plc, Imperial Tobacco and Elder Pharma, etc. Pfizer, Cipla, Novartis International are top 3 players and held % share in total in 2022.
Anti-Smoking Products can be divided into Nicotine Replacement Therapy, Drug therapy and E-cigarettes,, etc. Nicotine Replacement Therapy is the mainstream product in the market, accounting for % share globally in 2022.
Anti-Smoking Products is widely used in various fields, such as Smokers aged 18–24, Smokers aged 25–44, Smokers aged 45–64 and Smokers aged 65 years or older, etc. Smokers aged 18–24 provides greatest supports to the Anti-Smoking Products industry development. In 2022, global % share of Anti-Smoking Products went into Smokers aged 18–24 filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anti-Smoking Products market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Pfizer
Cipla
Novartis International
GSK
Takeda pharmaceutical
McNeil AB
Revolymer plc
Imperial Tobacco
Elder Pharma
NJOY
VMR products
Lorillard
VaporCorp
Segment by Type
Nicotine Replacement Therapy
Drug therapy
E-cigarettes
Segment by Application
Smokers aged 18–24
Smokers aged 25–44
Smokers aged 45–64
Smokers aged 65 years or older
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Anti-Smoking Products market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Anti-Smoking Products introduction, etc. Anti-Smoking Products Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Anti-Smoking Products market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices